Ellevest Inc’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-301
Closed -$74K 1999
2022
Q3
$74K Buy
301
+140
+87% +$37.8K 0.01% 481
2022
Q2
$40K Buy
161
+59
+58% +$15.9K ﹤0.01% 614
2022
Q1
$34K Buy
102
+43
+73% +$13.2K ﹤0.01% 623
2021
Q4
$21K Hold
59
﹤0.01% 714
2021
Q3
$19K Sell
59
-2
-3% -$678 ﹤0.01% 691
2021
Q2
$19K Buy
61
+3
+5% +$920 ﹤0.01% 657
2021
Q1
$18K Buy
58
+2
+4% +$640 ﹤0.01% 681
2020
Q4
$18K Sell
56
-5
-8% -$1.38K ﹤0.01% 656
2020
Q3
$17K Buy
61
+5
+9% +$1.44K ﹤0.01% 559
2020
Q2
$14K Sell
56
-3
-5% -$602 ﹤0.01% 559
2020
Q1
$9K Buy
59
+9
+18% +$1.49K ﹤0.01% 575
2019
Q4
$9K Buy
+50
New +$9.27K ﹤0.01% 547

Other funds holding ABMD

Ellevest Inc's ABMD Position: Q4 2022 in Review

Ellevest Inc sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 301 shares — an estimated $74K sold.

Ellevest Inc first reported a position in ABMD in Q4 2019 and held it in 12 quarters. The position peaked at $74K in Q3 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Ellevest Inc reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Ellevest Inc sold 301 Abiomed Inc shares in Q4 2022, an estimated $74K.
  • Ellevest Inc first reported a position in Abiomed Inc in Q4 2019 and held it in 12 quarters.
  • Ellevest Inc's Abiomed Inc position peaked at $74K in Q3 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Ellevest Inc's 13F filing for Q4 2022, filed 3 Feb 2023.